Clinuvel Pharmaceuticals (ASX:CUV) confirmed that its American Depositary Share (ADS) began trading on the Nasdaq Stock Market on Monday under the ticker symbol "CUVL," according to a Tuesday Australian bourse filing.
This completed the uplift of the firm's previous American Depositary Receipt, "CLVLY," from Level I to Level II.